United Kingdom · Question · Written question
UIN 190074
Cancer: Drugs
Introduced
19 June 2023
Last action
13 July 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 July 2023
Summary
To ask the Secretary of State for Health and Social Care, if he will monitor the impact of the severity modifier on access to new end of life cancer medicines.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 June 2023
Written question
To ask the Secretary of State for Health and Social Care, if he will monitor the impact of the severity modifier on access to new end of life cancer medicines.
Source: Commons
13 July 2023
Answer
The National Institute for Health and Care Excellence (NICE) is able to recommend the vast majority of cancer medicines it appraises and its approval rate for cancer medicines has consistently been around 90%. NICE concluded a comprehensive review of its ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-06-19/190074
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1645688
- uk · wq-1645688 · source updated 13 July 2023